BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15225751)

  • 1. Role of residues 143 and 278 of the human nuclear Vitamin D receptor in the full-length and Delta165-215 deletion mutant.
    Acevedo A; Stoynova L; Davis K; Solórzano R; Collins ED
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):83-7. PubMed ID: 15225751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residues of the human nuclear vitamin D receptor that form hydrogen bonding interactions with the three hydroxyl groups of 1alpha,25-dihydroxyvitamin D3.
    Reddy MD; Stoynova L; Acevedo A; Collins ED
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):347-51. PubMed ID: 17257828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
    J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of a deletion mutation (c.716delA) in the ligand binding domain of the vitamin D receptor in an Indian patient with vitamin D-dependent rickets type II.
    Kanakamani J; Tomar N; Kaushal E; Tandon N; Goswami R
    Calcif Tissue Int; 2010 Jan; 86(1):33-41. PubMed ID: 19921089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor interacts with DnaK/heat shock protein 70: identification of DnaK interaction site on vitamin D receptor.
    Swamy N; Mohr SC; Xu W; Ray R
    Arch Biochem Biophys; 1999 Mar; 363(2):219-26. PubMed ID: 10068443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor.
    Shaffer PL; McDonnell DP; Gewirth DT
    Biochemistry; 2005 Feb; 44(7):2678-85. PubMed ID: 15709781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.
    Yamamoto K; Masuno H; Choi M; Nakashima K; Taga T; Ooizumi H; Umesono K; Sicinska W; VanHooke J; DeLuca HF; Yamada S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1467-72. PubMed ID: 10677485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
    J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nuclear localization signal between the two DNA-binding zinc fingers in the human vitamin D receptor.
    Hsieh JC; Shimizu Y; Minoshima S; Shimizu N; Haussler CA; Jurutka PW; Haussler MR
    J Cell Biochem; 1998 Jul; 70(1):94-109. PubMed ID: 9632111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling.
    Quack M; Carlberg C
    Mol Pharmacol; 2000 Feb; 57(2):375-84. PubMed ID: 10648648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function.
    Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D
    Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-mediated conformational changes of the VDR are required for gene transactivation.
    Carlberg C
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):227-32. PubMed ID: 15225776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor.
    Yamada S; Shimizu M; Yamamoto K
    Med Res Rev; 2003 Jan; 23(1):89-115. PubMed ID: 12424754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of ligand-dependent transactivation regions of the human vitamin D receptor].
    Nakajima S
    Nihon Rinsho; 1998 Jul; 56(7):1717-21. PubMed ID: 9702043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of VDR in the activation of p27Kip1 by the VDR/Sp1 complex.
    Cheng HT; Chen JY; Huang YC; Chang HC; Hung WC
    J Cell Biochem; 2006 Aug; 98(6):1450-6. PubMed ID: 16518840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic nucleoporin CAN/Nup214 interacts with vitamin D receptor and modulates its function.
    Miyauchi Y; Sakaguchi N; Okada T; Makishima M; Ozono K; Michigami T
    J Cell Biochem; 2009 Apr; 106(6):1090-101. PubMed ID: 19229862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
    Healy KD; Frahm MA; DeLuca HF
    Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.